Search Results - Bader-Meunier, B
- Showing 1 - 20 results of 33
- Go to Next Page
-
1
Safety of rituximab in children with auto-immune diseases by Bader-Meunier, B, Quartier, P, Wouters, C
Published 2008Text -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics by Remy Piccolo, V, Sotou-Bere, S, Woerner, A, Mouy, R, Florkin, B, Bader-Meunier, B, Quartier, P
Published 2013Text -
15
PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring by Woillard, JB, Bader-Meunier, B, Salomon, R, Ranchin, B, Decramer, S, Fischbach, M, Berard, E, Saint-Marcoux, F
Published 2013Text -
16
-
17
-
18
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... by Ruperto, N, Quartier, P, Wulffraat, N, Woo, P, Loy, A, Mouy, R, Bader-Meunier, B, Prakken, B, Noseda, E, Rordorf, C
Published 2008Text -
19
-
20
Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients by Bader-Meunier, B, Hachulla, P, Kuemmerle-Deschner, J, Gattorno, M, Patel, N, Preiss, R, Lheritier, K, Imagawa, T, Nishikomori, R, Takada, H, Heike, T, Hara, T, Yokota, S
Published 2011Text